SSJR is pleased to report it has successfully defended its client Sandoz against a motion by Otsuka Pharmaceutical to amend an ANDA Complaint to add new claims for commercial and willful infringement.
Search LIBRARY
Details
Topics
SSJR Successfully Defends its Client Sandoz Against Motion to Amend ANDA Complaint
9 December 2008
TOPIC TAGS for this article: > Pharma + Biotech > Litigation